This study demonstrated that the status of MALAT-1 expression independently predicted overall survival in ccRCC, suggesting that MALAT-1 could serve as a potential therapeutic target for inhibiting ccRCC progression [66]. This evidence concerns the gene MALAT1 and nonpapillary renal cell carcinoma.